Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 22.067% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CC1=C(C)NC(=S)SC1
b) Cc1ccc(C2=NC(C(F)(F)F)(C(F)(F)F)c3c(n(-c4ccc(F)cc4)c(=O)[nH]c3=O)N2)cc1
c) CCn1cc(C(=O)NCc2ccc(OC)cc2)c(=O)c2ccc(C)nc21
Answer: c. CCn1cc(C(=O)NCc2ccc(OC)cc2)c(=O)c2ccc(C)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1cc(C(=O)NCc2ccc(OC)cc2)c(=O)c2ccc(C)nc21
CCn1cc(C(=O)NCc2ccc(OC)cc2)c(=O)c2ccc(C)nc21
1-ethyl-N-[(4-methoxyphenyl)methyl]-7-methyl-4-oxo-1,8-naphthyridine-3-carboxamide